文献速递胸部外周血管CTDSA

COVID-19患者CT肺动脉造影中的肺血栓栓塞性疾病——患病率、病变模式及与D-二聚体的关系

Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer.
PubMed 文献 · Eur J Radiol · 2020-10-06

研究纳入2020年3月1日至4月30日大曼彻斯特地区5家医院接受CTPA的84例COVID-19患者,38%(32/84)检出肺血栓栓塞,75%位于小血管、72%位于有COVID-19改变的肺叶;中重度COVID-19患者PTE比例更高(p=0.005),PTE组D-二聚体中位数6441 mcg/L,D-二聚体阈值2247 mcg/L对应敏感度0.72、特异度0.74。

要点

  • COVID-19患者CTPA中肺血栓栓塞患病率为38%(32/84),以小腿血管受累为主(75%)。
  • 中重度COVID-19患者中84%(27/32)合并PTE,疾病严重程度与PTE相关(p=0.005)。
  • D-二聚体阈值2247 mcg/L诊断PTE的敏感度0.72、特异度0.74。

核心结论

  • 中重度COVID-19患者中肺血栓栓塞患病率增高。
  • D-二聚体值可能有助于指导抗凝治疗和预后判断。

研究设计与样本

  • 回顾性纳入2020年3月1日至4月30日大曼彻斯特地区5家医院确诊COVID-19并接受CTPA的患者84例。
  • 评估CTPA上PTE的有无、分布(小血管和/或大血管)及在有无COVID-19改变的肺叶内的分布,并对COVID-19肺部改变严重程度分级。
  • 获取CTPA前72小时内D-二聚体值,进行统计学分析,p≤0.05为有统计学意义。

关键影像表现/征象

  • 38%(32/84)的COVID-19患者CTPA检出PTE。
  • PTE累及小血管者占75%(24/32),位于显示COVID-19改变的肺叶者占72%(23/32)。

诊断标准与关键数值

  • D-二聚体阈值2247 mcg/L诊断PTE的敏感度0.72、特异度0.74。
  • PTE阳性患者中84%(27/32)COVID-19疾病严重程度为中等或更高评分(p=0.005)。
  • PTE组D-二聚体中位数6441 mcg/L(范围219-90925),显著高于无PTE组(p≤0.001)。

临床应用与阅片要点

  • 对中重度COVID-19患者行CTPA时应注意评估小血管内PTE。
  • 阅片时需关注有COVID-19改变的肺叶内是否合并PTE。
  • D-二聚体值可能有助于指导抗凝治疗和预后判断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To define the prevalence of pulmonary thromboembolic (PTE) disease diagnosed on CT pulmonary angiography (CTPA) in COVID-19 patients. To assess distribution of PTE and to evaluate for association between severity of COVID-19 disease, D-dimer values and incidence of PTE.

METHODS: Patients with diagnosis of COVID-19 presenting to 5 different hospitals across Greater Manchester between 1st March 2020 and 30th April 2020 who had CTPA were included. CTPA images were evaluated for presence of PTE, distribution of PTE (in small and/or large vessels) and distribution of PTE within lungs with or without COVID-19 CT changes. Severity of COVID lung changes were graded. D-dimer values within 72 h of CTPA were obtained. Statistical analyses were performed to evaluate for any significant association between variables. p values of ≤0.05 were regarded as statistically significant.

RESULTS: A total of 974 patients presented across five hospital sites with COVID-19 infection. Eighty-four (n = 84) COVID-19 patients underwent CTPA. Of these, 38 % (32/84) had PTE. PTE was seen in small vessels in 75 % (24/32) and in lungs demonstrating COVID-19 changes in 72 % (23/32). 84 % (27/32) of PTE positive patients had disease severity of moderate or higher score (p = 0.005). D-dimer values were significantly higher (p ≤ 0.001) in PTE patients, median value in PTE group was 6441mcg/L (range 219-90925). A D-dimer cut off value of 2247mcg/L provides sensitivity of 0.72 and specificity of 0.74.

CONCLUSION: There is increased prevalence of PTE in patients with moderate to severe COVID-19 disease. D-dimer values may have potential in guiding anticoagulation therapy and prognostication.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ooi MWX, Rajai A, Patel R, et al. Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer. Eur J Radiol. 2020. PMID: 33069986. doi:10.1016/j.ejrad.2020.109336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。